CANCER MANAGEMENT AND RESEARCH, vol.14, pp.1911-1921, 2022 (SCI-Expanded, Scopus)
Introduction: The aim of this study was to evaluate treatment responses, toxicity, and survival among cHL patients aged >= 50 years.